Ranking Alexa Global: # 6,104,939
The main IP address: 185.19.14.33,Your server United Kingdom,London ISP:Ocean Unified Communications Limited TLD:com CountryCode:GB
The description :cookie policy mereo biopharma group plc's website uses cookies. by continuing to browse you are agreeing to our use of cookies. find out more about our cookie policy. mph : 315.00 company pipeline inv...
This report updates in 06-Aug-2018
Created Date: | 2015-02-25 |
Changed Date: | 2018-06-18 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host mereobiopharma.com. Currently, hosted in United Kingdom and its service provider is Ocean Unified Communications Limited .
Latitude: | 51.508529663086 |
Longitude: | -0.12574000656605 |
Country: | United Kingdom (GB) |
City: | London |
Region: | England |
ISP: | Ocean Unified Communications Limited |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 4629 |
Content-Encoding: | gzip |
Vary: | Accept-Encoding |
Cache-Control: | private |
Date: | Mon, 06 Aug 2018 00:48:20 GMT |
Content-Type: | text/html; charset=utf-8 |
soa: | ns.123-reg.co.uk. hostmaster.mereobiopharma.com. 2015122102 14400 0 604800 14400 |
txt: | "google-site-verification=ZdroyDAR12CnZ-NakF3JK1ztDYW2CQBR5SA7rykSm10" "v=spf1 include:spf.protection.outlook.com include:spf.exclaimer.net include:servers.mcsv.net -all" |
ns: | ns.123-reg.co.uk. ns2.123-reg.co.uk. |
ipv4: | IP:185.19.14.33 ASN:60793 OWNER:OCEAN-AS, GB Country:GB |
mx: | MX preference = 10, mail exchanger = mereobiopharma-com.mail.protection.outlook.com. |
cookie policy mereo biopharma group plc's website uses cookies. by continuing to browse you are agreeing to our use of cookies. find out more about our cookie policy. mph : 315.00 company pipeline investors partnering news and media contact us mph: 315.00 unlocking healthcare potential for patients leveraging our expertise to address unmet medical needs see our latest news our strategy mereo biopharma is an innovative leader in the biopharma sector with a focus on developing and optimizing the value of novel medicines acquired from large pharmaceutical companies designed to address significant unmet medical needs in rare and specialty disease areas. mereo biopharma plans to build a rare and orphan disease commercial business based on products acquired from major pharmaceutical companies. find out more about our strategy our products mereo has built an initial mid-late stage portfolio of four exceptionally well characterised novel products, three from novartis and one from astra zeneca, for the treatment of diseases with considerable unmet medical need. each of these programmes has a comprehensive dataset for both pre-clinical and initial phase 2 clinical studies. investors share price 315.00 gbp change: 0.00 0.00% market cap: £ 224.41m last updated: 06 aug 2018 01:48 view share price chart news 23 jul 2018 notice of results 21 jun 2018 result of annual general meeting 29 may 2018 successful completion of primarybid offer view all news events and conferences 18 may 2018 aether phase 2 clinical trial data to be presented at the american thoracic society meeting in san diego, 18 to 23 may 26 sep 2017 mereo biopharma to present at the cantor global healthcare conference in new york, 25-27 september 2017 19 may 2017 mereo biopharma presented at at the american thoracic society meeting in washington, 19-24 may 2017 view all events follow us on linkedin follow us on twitter register for email alerts privacy policy cookie policy terms and conditions other legal notices sitemap urgent medical enquiries careers mereo biopharma group plc © 2018 mereo biopharma group plc ("mereo") is incorporated in england and wales and the uk is the company's main country of operation. the company is subject to the city code on takeovers and mergers (the city code) issued and administered by the panel on takeovers and mergers (the takeover panel). the company's shareholders are entitled to the protections afforded by the city code. emperor.works
http://www.mereobiopharma.com/terms-conditions/
http://www.mereobiopharma.com/careers/
http://www.mereobiopharma.com/investors-page/share-price/share-price-chart/
http://www.mereobiopharma.com/news-and-media/press-releases/2018/notice-of-results/notice-of-results/
http://www.mereobiopharma.com/news-and-media/press-releases/
http://www.mereobiopharma.com/investors-page/register-for-email-alerts/
http://www.mereobiopharma.com/news-and-media/events-and-conferences/
http://www.mereobiopharma.com/contact-us/
http://www.mereobiopharma.com/company/
http://www.mereobiopharma.com/privacy-policy/
http://www.mereobiopharma.com/news-and-media/
http://www.mereobiopharma.com/partnering/
http://www.mereobiopharma.com/urgent-medical-enquiries/
http://www.mereobiopharma.com/other-legal-notices/
http://www.mereobiopharma.com/sitemap/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: MEREOBIOPHARMA.COM
Registry Domain ID: 1905411523_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2018-06-18T07:23:32Z
Creation Date: 2015-02-25T10:59:41Z
Registry Expiry Date: 2019-02-25T10:59:41Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.123-REG.CO.UK
Name Server: NS2.123-REG.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-08-06T00:48:15Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR 123-Reg Limited
SERVERS
SERVER com.whois-servers.net
ARGS domain =mereobiopharma.com
PORT 43
TYPE domain
DOMAIN
NAME mereobiopharma.com
CHANGED 2018-06-18
CREATED 2015-02-25
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
NS.123-REG.CO.UK 212.67.202.2
NS2.123-REG.CO.UK 62.138.132.21
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .